Real-world study shows IPSS-M improves risk prognostication and transplant selection in myelodysplastic syndromes, indicating the utility of defining a core gene set for clinical use.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sauta et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: